All News

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

Older adults with dementia face significantly higher COVID-19 risks, highlighting the need for targeted health strategies during pandemics.

FDA approves lumateperone as an adjunct therapy for major depressive disorder, offering new treatment options for this indication.

A study reveals tailored glucose monitoring intervals for type 2 diabetes patients based on HbA1c levels, enhancing long-term management strategies.

Episode 4 of Wicked Good Cardiometabolic Chat explores SGLT2 inhibitors and their efficacy beyond just diabetes outcomes.

Experts discuss the implications of the Most Favored Nation drug policy, discussing its impact on pricing, community pharmacy, and patient safety in the final part of a webinar series.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses risks and approaches associated with severe insulin resistance among mothers and their children.

Due to humans’ physiologically premature nature, researchers explore maternal psychological distress and childhood neurodevelopment.

Pharmacy evolves from product-based to holistic care, emphasizing clinical services and patient management, driven by passionate future pharmacists.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.

A study reveals a significant decline in inhaled corticosteroid use among COPD patients, highlighting the need for careful management and monitoring.

Researchers explore OTC naloxone sales sold independently at pharmacies and programmatically from 2023 to 2024.

Conversations about contraceptive options have grown more frequent—and often more polarized—on social media platforms.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses his experience in diabetes care and how the pharmacist’s role has evolved throughout his professional career.

Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.

Lisa Schwartz, PharmD, discusses the importance of the Medicare Transaction Facilitator as community pharmacies head into a new year of the Medicare Drug Price Negotiation Program.

The FDA releases its updated recommendations and scientific considerations for the demonstration of safety and efficacy among biosimilars and their reference products.

In the final part of our interview with Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, they discuss the relationships between state- and federal-level PBM reform.

A recent study reveals COVID-19 vaccine safety and varying disease activity impacts for systemic lupus erythematosus patients, highlighting important insights for immunization.

From the COVID-19 pandemic through state-by-state expansion of scope, pharmacists have tapped into a variety of their clinical skills to bolster patient outcomes in their communities.

In part 4 of our interview with Jennifer Griffin, PharmD, MS, she discusses different payer engagement models and the pharmacists’ ability to understand and improve medical billing tactics.

The regimen did not show signs of significant hypoglycemia and had a low prevalence of edema despite modest weight gain.

At the NCPA 2025 Annual Convention & Expo, Lucas Morgan, Esq, shareholder with Buchanan Ingersoll & Rooney, joined us to discuss ongoing PBM legislation in the state of Arkansas.

Alyssa Mack, PharmD, pharmacist at Gibbs Pharmacy and Compounding Center, discusses how expanding clinical services can simultaneously benefit patients and the pharmacy profession.

Leaders of the FDA, the US Department of Health and Human Services, and the Centers for Medicare & Medicaid Services announce new guidelines and a framework for less expensive biosimilar development.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.